ESCRS - Pathophysiology of neurotrophic keratopathy ;
ESCRS - Pathophysiology of neurotrophic keratopathy ;

Pathophysiology of neurotrophic keratopathy

Pathophysiology of neurotrophic keratopathy
Leigh Spielberg
Leigh Spielberg
Published: Friday, October 6, 2017
    Professor Harminder Dua Professor Harminder Dua, Queen's Medical Centre, Nottingham, UK, addressed delegates at the 8th EuCornea Congress in Lisbon on the topic of “Pathophysiology of neurotrophic keratoplasty” (NK). “As we all know, the cornea is the most richly innervated structure in the human body, and these nerves have not only sensory functions, but also crucial trophic functions,” said Dr Dua. These trophic functions stimulate the release of neuromediators that provide trophic support to corneal epithelial cells and keratocytes, providing a range of biologically active neurochemicals, such as nerve growth factor (NGF), that contribute to the maintenance of a healthy ocular surface. They are, in turn, supported by trophic substances produced by epithelial cells and keratocytes. “Loss of corneal sensory innervation leads to decreased corneal epithelial renewal rate, reduced tear formation and blinking and ultimately development of NK,” he said. The neurological dysfunction not only lies at the aetiology of the disease, but can also influence the presentation and progression of diseases such as infectious keratitis, with a far less pronounced inflammatory and vascular reaction. This is relevant not only for corneal specialists in tertiary referral centres, but also for general ophthalmologists who perform refractive surgery. Dr Dua noted that: “Even years after LASIK, corneal innervation can remain structurally abnormal. Whether that is functionally important, we don’t yet know, but the ‘pain without stain’ phenomenon might be due to hyper-regeneration of nerves, leading to hyperesthesia and patient complaints.”
Latest Articles
From Lab to Life: Corneal Repair Goes Cellular

Long-awaited cellular therapies for corneal endothelial disease enter the clinic.

Read more...

Balancing Innovation and Safety

Ensuring access to advanced cell therapies amid regulatory overhaul.

Read more...

With Eyes on Its Future, ESCRS Celebrates Its Past

Winter Meeting offers opportunities to experiment with new concepts and formats.

Read more...

Best of ESCRS Winter Meeting 2024

Read more...

Following the New Generation

EDOF IOLs an option for eyes with mild comorbidities, showing potential in mini-monovision strategies.

Read more...

Refocus on Multifocals

Trifocal IOLs continue to improve as consensus grows regarding indications and contraindications.

Read more...

Common Myths in Presbyopia Correction

Patient education key to satisfaction with refractive IOLs.

Read more...

Reversible Multifocality

Two-lens combination offers low-risk spectacle independence for cataract patients and presbyopes.

Read more...

Managing a Cataract Surgery Refractive Miss

Weighing the pros and cons of options for intraocular intervention.

Read more...

Unleashing OCT’s Full Potential

Performance of newest tool for corneal evaluation meets or beats older standard technologies.

Read more...

;